Jimmy Huang, DO
Family Medicine · Los Angeles, CANPI 1780649442
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,030 of the $3,772 with a category attached, or 80.3%. Janssen Scientific Affairs, LLC accounts for 96.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $3,683 and has fallen 99.5% since, to $18 in 2024. Among family medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 10 payments — averaging $377.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$4K
- Sunovion Pharmaceuticals Inc.$45
- Smith+Nephew$23
- Acadia Pharmaceuticals Inc$23
- Otsuka America Pharmaceutical, Inc.$18
- Johnson & Johnson$13
What the payments were for
- Consulting fees$3,03080%
- Travel & lodging$56915%
- Food & beverage$1725%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 4 | $3,649 |
| Sunovion Pharmaceuticals Inc. | 2 | $45 |
| Smith+Nephew | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Erleada$3,599
How this compares
$3,772 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 470 | $123,945 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 23 | $97,672 |
| Invega SustennaPaliperidone Palmitate | 34 | $94,407 |
| JanuviaSitagliptin Phosphate | 207 | $64,047 |
| EntrestoSacubitril/Valsartan | 143 | $48,370 |
| SantylCollagenase Clostridium Hist. | 66 | $46,667 |
| JardianceEmpagliflozin | 109 | $29,673 |
| XareltoRivaroxaban | 66 | $17,687 |
| Divalproex Sodium | 509 | $15,013 |
| Pantoprazole Sodium | 340 | $13,915 |
| Atorvastatin Calcium | 1,196 | $13,447 |
| Gabapentin | 623 | $10,520 |
| Chlorpromazine Hcl | 46 | $10,208 |
| Memantine Hcl | 329 | $9,935 |
| Spiriva HandihalerTiotropium Bromide | 20 | $8,491 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Xarelto | $13 | $112,094100 claims |
| Smith+NephewSantyl | $23 | $46,66766 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in Los Angeles
- Pamela KushnerLos Angeles$1.2M
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Jacqueline KenneyLos Angeles$121K
- Sherly SoleimanEncino$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.